Plain-English translation of NCT07497880 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can help adults with obesity or overweight lose weight. Participants will take the medication once a day (or a placebo) for a set period while researchers measure how much weight people lose and how safe the treatment is. The study includes people with weight-related health conditions like high blood pressure, high cholesterol, sleep apnea, or heart disease—and also welcomes people with type 2 diabetes.
Many people struggle to lose weight with diet and exercise alone, and extra weight can lead to serious health problems. This trial is testing whether this new medication can be a helpful tool to support weight loss and improve overall health in people living with obesity or overweight.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic multiple times over the course of the study. At each visit, the team will check your weight, measure other health markers, and make sure the medication is working well and causing no serious side effects. You'll take the medication (or placebo) once daily at home between visits. Some participants will receive one of four different dose levels of the medication, while others will receive a placebo so researchers can compare results fairly.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States